FMP
Checkmate Pharmaceuticals, Inc.
CMPI
NASDAQ
Inactive Equity
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.
10.5 USD
0 (0%)
About
ceo
Mr. Barry A. Labinger
sector
Healthcare
industry
Biotechnology
website
https://www.checkmatepharma.com
exchange
NASDAQ
Description
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regene...
CIK
0001651431
ISIN
US1628181083
CUSIP
162818108
Address
245 Main Street
Phone
617 682 3625
Country
US
Employee
30
IPO Date
Aug 7, 2020
Summary
CIK
0001651431
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
162818108
ISIN
US1628181083
Country
US
Price
10.5
Beta
0
Volume Avg.
233.02k
Market Cap
0
Shares
-
52-Week
10.49-10.5
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-3.85
P/B
-
Website
https://www.checkmatepharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CMPI News
It looks like there's no news available.
